Jiří Schimer
Impact in
- Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Multicomponent Synthesis of Heterocycles
-
- HIV Research and Treatment
Papers in
-
- Amino Acid Enzymes and Metabolism 3
-
- Protease and Inhibitor Mechanisms 3
- Co-authors
- Jan Konvalinka (12 shared papers)Petr Cígler (8 shared papers)Ján Veselý (3 shared papers)Pavel Šácha (8 shared papers)Ivana Cı́sařová (2 shared papers)Guillem Valero (2 shared papers)Albert Moyano (2 shared papers)Ramón Rios (2 shared papers)
- Journals
- ACS Nano (3 papers)Journal of Medicinal Chemistry (3 papers)Nature Communications (1 paper)ACS Omega (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- CzechiaGermanyUnited States
In The Last Decade
Jiří Schimer
22 papers receiving 713 citations
Peers
Comparison fields: 5 of 63
- Organic Chemistry 227
- Virology 26
- Biomaterials 61
- Radiology, Nuclear Medicine and Imaging 90
- Biophysics 27
Countries citing papers authored by Jiří Schimer
This map shows the geographic impact of Jiří Schimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Schimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Schimer more than expected).
Fields of papers citing papers by Jiří Schimer
This network shows the impact of papers produced by Jiří Schimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Schimer. The network helps show where Jiří Schimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiří Schimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2009 | 78 | |
| 3 | 2012 | 60 | |
| 4 | 2020 | 54 | |
| 5 | 2014 | 49 | |
| 6 | 2014 | 43 | |
| 7 | 2011 | 37 | |
| 8 | 2016 | 34 | |
| 9 | 2015 | 32 | |
| 10 | 2016 | 30 | |
| 11 | 2022 | 29 | |
| 12 | 2015 | 25 | |
| 13 | 2016 | 23 | |
| 14 | 2017 | 23 | |
| 15 | 2019 | 21 | |
| 16 | 2023 | 19 | |
| 17 | 2016 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2019 | 15 | |
| 20 | 2020 | 10 |
About Jiří Schimer
Jiří Schimer is a scholar working on Biochemistry, Cancer Research, Virology, Oncology and Infectious Diseases, having authored 22 papers that have together received 722 indexed citations. Recurring topics across this work include Diamond and Carbon-based Materials Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (3 papers), Amino Acid Enzymes and Metabolism (3 papers), HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Organic Chemistry (227 citations), Virology (26 citations), Biomaterials (61 citations), Radiology, Nuclear Medicine and Imaging (90 citations) and Biophysics (27 citations). Jiří Schimer has collaborated with scholars based in Czechia, Germany and United States. Frequent co-authors include Jan Konvalinka, Petr Cígler, Ján Veselý, Pavel Šácha, Ivana Cı́sařová, Guillem Valero, Albert Moyano, Ramón Rios, Pavel Majer and Jan Tykvart. Their work appears in journals such as ACS Nano, Journal of Medicinal Chemistry, Nature Communications, ACS Omega and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.